Akbarian, Schahram
- Icahn School of Medicine at Mount Sinai · Internal Medicine (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #15,361
- Sustained Excellence
- R01 Holder
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2001 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Internal Medicine
NIH Funding · FY2023
Linked Award Amount
$729.3K
Full award amounts, FY2023
Award Records
1
Records listing this PI
Award-Linked Rank
#15,361
By linked amount among FY2023 PIs
Earliest Year Loaded
2001
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Akbarian, Schahram as a PI. Multi-PI records show the full award amount for context.
- 1R01MH134319-01R01Contact PICell-lineage specific epigenomic determinants of HIV latency in humanized mouse brain and bloodIcahn School of Medicine at Mount Sinai · Internal Medicine (NIH department code)$729.3Kaward amount
Award organization
Organizations that administered FY2023 awards listing Akbarian, Schahram as a PI.
FY2023 award administered by Icahn School of Medicine at Mount Sinai (NY).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2001First NIH AwardIcahn School of Medicine at Mount Sinai
- 2003$500K Cumulative Funding
- 2005$1M Cumulative Funding
- 2005Entered Top 50% NationallyRanked #3275
- 2005Entered Top 25% NationallyRanked #3275
- 2013$2M Cumulative Funding
- 2013R01 Grant Holder
- 2016$5M Cumulative Funding
- 2017Entered Top 10% NationallyRanked #1738
- 2018$10M Cumulative Funding
- 2018Entered Top 5% NationallyRanked #784